X0508 4 2024-03-05 0001777921 AvePoint, Inc. AVPT 0001865596 Jiang Tianyi C/O AVEPOINT, INC. 525 WASHINGTON BOULEVARD, SUITE 1400 JERSEY CITY NJ 07310 1 1 1 Chief Executive Officer 0 Common Stock 2024-03-05 4 A 0 134048 0 A 586599 D Stock Option (Right to Buy) 7.46 2024-03-05 4 A 0 234960 7.46 A 2025-03-05 2035-03-05 Common Stock 234960 5888197 D This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. Represents performance-based RSUs based upon two metrics: FY25 GAAP Profitability and Non-GAAP Rule of 40. Actual payouts may represent 50% to 150% of granted value. These performance-based RSUs will vest 50% on March 5, 2026, and then 25% annually after, using FY25 as the performance period. Includes aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I on a Form 4 filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022 and March 23, 2023. This security represents options to purchase the Issuer's common stock granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. 25% of the shares underlying this option will vest on March 5, 2025, and the remaining options vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. This security represents options to purchase the Issuer's common stock granted to the reporting person under the Issuer's 2021 Equity Incentive Plan. Each option represents the contingent right to receive, upon exercise of the option, one share of the Issuer's common stock. /s/ Brian Michael Brown, Attorney-in-Fact 2024-03-07